Dr Miruna Sasu: The FDA Can Help to Clean Up and Improve RWD Capture
Miruna Sasu, PhD, MBA, president and CEO of COTA Healthcare, discusses 3 ways in which the FDA can provide, and has provided, assistance on the capture of real-word data (RWD)...
News from the healthcare data industry
Miruna Sasu, PhD, MBA, president and CEO of COTA Healthcare, discusses 3 ways in which the FDA can provide, and has provided, assistance on the capture of real-word data (RWD)...
April 20, 2022 07:00 ET | Source: Tonix Pharmaceuticals Holding Corp. Over 40% of Long COVID Patients Had Fibromyalgia-Like Multi-Site Pain Symptoms Rate of Opioid Use in Long COVID Patients with Multi-Site...
Cambridge, MA, April 4, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, enabled researchers at Hospital Universitario 12 de Octubre...
TUESDAY MARCH 8TH, 2022 Those without boosters nearly two times more likely to get COVID-19 during Omicron surge, with greater risk for those with co-morbidities BELLEVUE, Wash.– March 8, 2022...
FEB 22, 2022 | FEDSCOOP The Centers for Disease Control and Prevention will expand use of its Tiberius platform from COVID-19 vaccine distribution to therapeutics distribution and supply chain resiliency,...
SAN FRANCISCO, Feb. 8, 2022 /PRNewswire/ — Vault Health, a national leader in remote diagnostics and COVID testing, and Datavant, the leader in helping organizations securely de-identify and connect health data, today announced...
A new study found that some COVID-19 patients were diagnosed with shortness of breath, Type 2 diabetes and fatigue weeks after their initial infection.By Kat JercichFebruary 07, 202203:58 PM Photo: SHVETS...
The dermatology community remains concerned about the risk of COVID-19 in individuals with atopic dermatitis (AD). Using Symphony Health-derived data from the COVID-19 Research Database,1 we aimed to assess the risk...
Results validate company’s methodology and provide insight about the rapid evolution of future variants of concern January 18, 2022 08:45 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–nference, an AI-driven health...
CAMBRIDGE, Mass., Dec. 15, 2021 /PRNewswire/ — nference, the AI-driven health technology company, announced today publication of a peer-reviewed study in Med that analyzed Mayo Clinic based data with nference artificial intelligence (AI) software to...